6-(Cyclobutylamino)-9-methyl-8-phenyl-9H-purine

ID: ALA4165013

PubChem CID: 11492857

Max Phase: Preclinical

Molecular Formula: C16H17N5

Molecular Weight: 279.35

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1c(-c2ccccc2)nc2c(NC3CCC3)ncnc21

Standard InChI:  InChI=1S/C16H17N5/c1-21-15(11-6-3-2-4-7-11)20-13-14(17-10-18-16(13)21)19-12-8-5-9-12/h2-4,6-7,10,12H,5,8-9H2,1H3,(H,17,18,19)

Standard InChI Key:  ZMSLVSDECFRUFH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 24  0  0  0  0  0  0  0  0999 V2000
   12.6527   -3.8342    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6515   -4.6537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3596   -5.0627    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3578   -3.4253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0664   -3.8306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0667   -4.6537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8496   -4.9079    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.3333   -4.2418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8492   -3.5760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1473   -4.2401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5555   -4.9493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3720   -4.9493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7811   -4.2409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3679   -3.5310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5528   -3.5344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3553   -2.6081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1024   -5.6850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6464   -2.2016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4326   -1.4103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6438   -1.6242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8577   -2.4129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 10  1  0
  4 16  1  0
  7 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 18  1  0
M  END

Alternative Forms

Associated Targets(Human)

ADORA1 Tclin Adenosine receptors; A1 & A3 (1051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 279.35Molecular Weight (Monoisotopic): 279.1484AlogP: 2.99#Rotatable Bonds: 3
Polar Surface Area: 55.63Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.48CX LogP: 2.93CX LogD: 2.93
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.80Np Likeness Score: -1.01

References

1. Lambertucci C, Marucci G, Dal Ben D, Buccioni M, Spinaci A, Kachler S, Klotz KN, Volpini R..  (2018)  New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases.,  151  [PMID:29614417] [10.1016/j.ejmech.2018.03.067]

Source